The Ride of Peloton’s Life

Peloton has been on the ride of its life over the past few months. In late January, after declining nearly 24% in one day, Peloton is pedaling toward a (kind of?) recovery — rumors of a possible Peloton acquisition sent $PTON stock soaring 21% today.

Rumor has it that companies like Amazon, Apple, and Nike all have an interest in purchasing Peloton, with some analysts claiming Apple may be “aggressively involved” in talks with the fitness brand. The Financial Times named Nike a possible buyer, and the WSJ reported on Amazon’s potential talks with Peloton. Amazon’s interest may stem from the company’s ability to add Peloton fitness subscriptions to Prime.

One of Peloton’s stakeholders, Blackwells Capital, encouraged Peloton to consider a sale. Those familiar with the matter say Peloton CEO John Foley will probably not sell (Foley and insiders have 80% voting control) without a persistent stock selloff. That being said, Peloton’s market value currently sits at $8 billion, down $42 billion from its $50 billion valuation a year ago. 😬

Some analysts are questioning the financial soundness of a Peloton sale. Simeon Siegel of BMO Capital Markets commented “A company is worth what someone’s willing to pay for it. If a mega-cap decides to pay up for Peloton, that’s all that matters. However, until that happens, we question whether it’d make sense.” We’ll be keeping an eye on the Peloton drama for further updates. 👀

$PTON is down -0.30% in afterhours.

More in   M&A

View All

A Day Of Deals

It was a busy day on Wall Street, so let’s recap the buyouts, IPOs, and more dealmaking you might’ve missed. 👀

First up is the Mediterranean restaurant chain Cava confidentially filing for an IPO. The fast-casual restaurant was founded in 2006 and expanded in 2018 by buying Zoes Kitchen for $300 million. It recently raised $230 million in April 2021 at a valuation of $1.71 billion. Now, the company is looking to go public as the market reheats following an ice-cold 2022. 🥗

Read It

Another Day Of M&A

As usual, it was another busy Monday of mergers and acquisitions. Let’s recap the biggest deals. 📝

First, Danish pharmaceutical giant Novo Nordisk’s parent company is buying drug manufacturer Catelent for $16.5 billion to help boost the supply of popular weight loss injection Wegovy and diabetes shot Ozempic. Novo Nordisk will then buy three of Catalent’s manufacturing sites from its parent company for $11 billion, giving it further access to the fill-finish part of its Wegovy product. 🏭

Read It

For Musk, It’s “Funding Secured” On Twitter Buyout

An 11-day long fight between the world’s richest person and one of the most beloved social media platforms has come to a close: Elon Musk is buying Twitter

The deal’s terms haven’t changed — Musk will pay $44 billion, that’ll be $54.20/share — to acquire the site. Twitter originally didn’t take Musk’s deal seriously. In fact, the Board even imposed a “poison pill” to prevent Musk from acquiring more than 15% of the company.

Read It

FTX Goes Shopping Amid Market Turmoil

This article’s GIF essentially represents FTX Founder and CEO Sam Bankman-Fried pulling up to every struggling company right now. 😏

The highly-capitalized crypto exchange has been on a shopping spree amid the market turmoil, providing cash-strapped firms with a lifeline…for a price. 🏷️

Read It